Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYANOTECH CORPCYAN · Entity 8431 | COO | July 13, 2018 | July 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYANOTECH CORP
Report date July 13, 2018 · Filed July 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 2,238 |
Reported balance
After 2018-07-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-07-13 · Grant · Acquired 2,238 · Balance 2,238 F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2: The restricted stock units shall vest as to 746 shares on July 13, 2019, 746 shares on July 13, 2020 and 746 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 113 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 113 F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F3: The restricted stock units shall vest as to 57 shares on 4/5/2019 and 56 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. |
| Cyanotech common stockSEC Table I · non-derivative | Direct | 35 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 35 |
| Cyanotech common stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $4.72 · Expires 2024-08-18 | Direct | 45,000 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 45,000 F4: Mr Watts acquired 45,000 stock options on 8/18/2014, of which 15,000 options became exercisable on 8/18/2015, 15,000 options became exercisable on 8/18/2016, and 15,000 options became exercisable on 8/18/2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock.
F2: The restricted stock units shall vest as to 746 shares on July 13, 2019, 746 shares on July 13, 2020 and 746 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date.
F3: The restricted stock units shall vest as to 57 shares on 4/5/2019 and 56 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date.
F4: Mr Watts acquired 45,000 stock options on 8/18/2014, of which 15,000 options became exercisable on 8/18/2015, 15,000 options became exercisable on 8/18/2016, and 15,000 options became exercisable on 8/18/2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2018 Filed Jul 18, 2018 14:44 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted stock units · Derivative | 2,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013415 · rdgdoc.xml · derivative · entry 2 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,238 Underlying: Cyanotech common stock · 2,238 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 746 shares on July 13, 2019, 746 shares on July 13, 2020 and 746 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 746 shares on July 13, 2019, 746 shares on July 13, 2020 and 746 shares on July 13, 2021, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted stock units · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006541 · rdgdoc.xml · derivative · entry 4 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113 Underlying: Cyanotech common stock · 57 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 57 shares on 4/5/2019 and 56 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 57 shares on 4/5/2019 and 56 shares on 4/5/2020, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCyanotech common stock | 22 | $5.25 | $115.50 |
DisclosureSEC source: 0001437749-18-006541 · rdgdoc.xml · nonDerivative · entry 2 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35 F1 · kind: The reporting person is reporting the withholding by the Issuer of 22 shares of common stock that vested on April 5, 2018 pursuant to the April 5, 2017 RSU grant, but that were not issued in order to satisfy the reporting person's tax withholding obligations in connection with the delivery of the converted common stock to the reporting person as of April 6, 2018. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 14:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCyanotech common stock | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006541 · rdgdoc.xml · nonDerivative · entry 1 WATTS GERARD J · CIK 0001251119 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.